125 related articles for article (PubMed ID: 37098715)
1. Combination of bendamustine-azacitidine against Syk target of breast cancer: an
Muthumanickam S; Ramachandran B; Boomi P; Jeyakanthan J; Prabu HG; Jegatheswaran S; Premkumar K
J Biomol Struct Dyn; 2023; 41(23):13950-13962. PubMed ID: 37098715
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of Syk gene by AZA suppresses metastasis but not proliferation of breast cancer cells.
Xia TS; Shi JP; Ding Q; Liu XA; Zhao Y; Liu YX; Xia JG; Wang S; Ding YB
Med Oncol; 2012 Jun; 29(2):448-53. PubMed ID: 21347717
[TBL] [Abstract][Full Text] [Related]
3. Designing a novel drug-drug conjugate as a prodrug for breast cancer therapy: in silico insights.
Muthumanickam S; Ramachandran B; Jeyakanthan J; Jegatheswaran S; Pandi B
Mol Divers; 2024 Jun; ():. PubMed ID: 38833125
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness.
Yuan Y; Liu H; Sahin A; Dai JL
Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373
[TBL] [Abstract][Full Text] [Related]
5. An
Malkaje S; Srinivasa MG; Deshpande N S; Navada S; Revanasiddappa Bc
Curr Drug Res Rev; 2023; 15(1):88-100. PubMed ID: 36017854
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors.
Acar Çevik U; Celik I; Işık A; Ahmad I; Patel H; Özkay Y; Kaplancıklı ZA
J Biomol Struct Dyn; 2023 Mar; 41(5):1944-1958. PubMed ID: 35037830
[TBL] [Abstract][Full Text] [Related]
7. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
8. A review of synthetic strategy, SAR, docking, simulation studies, and mechanism of action of isoxazole derivatives as anticancer agents.
Arya GC; Khalid M; Mehla S; Jakhmola V
J Biomol Struct Dyn; 2024 Jun; 42(9):4909-4935. PubMed ID: 37315986
[TBL] [Abstract][Full Text] [Related]
9. Anti-breast cancer drugs targeting cell-surface glucose-regulated protein 78: a drug repositioning
Abu-Mahfouz A; Ali M; Elfiky A
J Biomol Struct Dyn; 2023; 41(16):7794-7808. PubMed ID: 36129131
[TBL] [Abstract][Full Text] [Related]
10. Rational design of 9-vinyl-phenyl noscapine as potent tubulin binding anticancer agent and evaluation of the effects of its combination on Docetaxel.
Dash SG; Suri C; Nagireddy PKR; Kantevari S; Naik PK
J Biomol Struct Dyn; 2021 Sep; 39(14):5276-5289. PubMed ID: 32608323
[TBL] [Abstract][Full Text] [Related]
11.
Parvizpour S; Elengoe A; Alizadeh E; Razmara J; Shamsir MS
J Biomol Struct Dyn; 2023 Nov; 41(19):10037-10050. PubMed ID: 36451602
[TBL] [Abstract][Full Text] [Related]
12. Bendamustine-PAMAM Conjugates for Improved Apoptosis, Efficacy, and in Vivo Pharmacokinetics: A Sustainable Delivery Tactic.
Gothwal A; Khan I; Kumar P; Raza K; Kaul A; Mishra AK; Gupta U
Mol Pharm; 2018 Jun; 15(6):2084-2097. PubMed ID: 29195048
[TBL] [Abstract][Full Text] [Related]
13.
Muthiah I; Rajendran K; Dhanaraj P; Vallinayagam S
J Biomol Struct Dyn; 2021 Aug; 39(13):4807-4815. PubMed ID: 32580684
[TBL] [Abstract][Full Text] [Related]
14. Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of Cannabis sativa in Breast Cancer.
Kikiowo B; Ogunleye AJ; Iwaloye O; Ijatuyi TT; Adelakun NS; Alashe WO
Recent Pat Anticancer Drug Discov; 2021; 16(2):273-284. PubMed ID: 33563181
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between hypermethylation of Syk gene promoter and medulloblastoma cell invasion and metastasis].
Ji HL; Shi PF; Zhou J; Mao TM; Luo YK; Chen X; Zhou KY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Feb; 32(2):132-136. PubMed ID: 29931864
[TBL] [Abstract][Full Text] [Related]
16. Modulation of interaction of BRCA1-RAD51 and BRCA1-AURKA protein complexes by natural metabolites using as possible therapeutic intervention toward cardiotoxic effects of cancer drugs: an
Tiwari S; Pandey VP; Yadav K; Dwivedi UN
J Biomol Struct Dyn; 2022; 40(23):12863-12879. PubMed ID: 34632941
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking of the pentapeptide derived from rice bran protein as anticancer agent inhibiting both receptor and non-receptor tyrosine kinases.
Gasymov OK; Kecel-Gunduz S; Celik S; Akyuz S; Ozel AE; Agaeva G; Suleymanova LM; Agaeva U; Bakhishova M; Aliyev JA
J Biomol Struct Dyn; 2023 Jul; 41(10):4321-4343. PubMed ID: 35477348
[TBL] [Abstract][Full Text] [Related]
18. Screening of phytochemicals as potential anti-breast cancer agents targeting HER2: an in-silico approach.
Lamichhane S; Rai RP; Khatri A; Adhikari R; Shrestha BG; Shrestha SK
J Biomol Struct Dyn; 2023 Feb; 41(3):897-911. PubMed ID: 34957911
[TBL] [Abstract][Full Text] [Related]
19. Molecular Modeling Strategies of Cancer Multidrug Resistance.
Yalcin-Ozkat G
Drug Resist Updat; 2021 Dec; 59():100789. PubMed ID: 34973929
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and
Lavanya KJ; Kaur K; Jaitak V
Curr Comput Aided Drug Des; 2024; 20(4):374-383. PubMed ID: 36944620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
